THYROID CANCER, PAPILLARY
Clinical trials for THYROID CANCER, PAPILLARY explained in plain language.
Never miss a new study
Get alerted when new THYROID CANCER, PAPILLARY trials appear
Sign up with your email to follow new studies for THYROID CANCER, PAPILLARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists try drug duo to Re-Sensitize stubborn thyroid tumors
Disease control CompletedThis early-stage study tested a combination of two drugs, vemurafenib and copanlisib, in patients with a specific type of advanced thyroid cancer that had stopped responding to standard radioactive iodine therapy. The main goals were to find the safest dose of the drug combinatio…
Matched conditions: THYROID CANCER, PAPILLARY
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Over half of thyroid cancer patients may need second surgery, study reveals
Diagnosis CompletedThis study looked at whether checking lymph nodes during initial thyroid cancer surgery helps doctors decide the right amount of tissue to remove. Researchers examined 110 patients with small, early-stage thyroid cancer who were scheduled for partial thyroid removal. They found t…
Matched conditions: THYROID CANCER, PAPILLARY
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Mar 12, 2026 13:51 UTC